The splicing factor SRSF1 as a marker for endothelial senescence

Frontiers in Physiology

Volumn 3 MAR, Issue , 2012, Pages

  Blanco, Francisco Javier ^a   Bernabéu, Carmelo ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Alternative splicing; Endoglin; Endothelial senescence; Progerin; SRSF1; Tissue factor; VEGF

Indexed keywords

EID: 84866270239     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00054     Document Type: Short Survey

References (60)

1. Bellon, T., Corbi, A., Lastres, P., Cales, C., Cebrian, M., Vera, S., Cheifetz, S., Massague, J., Letarte, M., and Bernabeu, C. (1993). Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur. J. Immunol. 23, 2340-2345.
2. Biamonti, G., and Caceres, J. F. (2009). Cellular stress and RNA splicing. Trends Biochem. Sci. 34, 146-153.
3. Blanco, F. J., and Bernabeu, C. (2011). Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence. Aging Cell 10, 896-907.
4. Blanco, F. J., and Bernabeu, C. (2012). "Alternative splicing in endothelial senescence. Role of the TGF-β co-receptor endoglin," in Senescence, ed. T. Nagata (InTech). Available from: http://www.intechopen.com/articles/show/title/alternative-splicing-in-endothelial-senescence-role-of-the-tgf-beta-co-receptor-endoglin
5. Blanco, F. J., Grande, M. T., Langa, C., Oujo, B., Velasco, S., Rodriguez-Barbero, A., Perez-Gomez, E., Quintanilla, M., Lopez-Novoa, J. M., and Bernabeu, C. (2008). S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology. Circ. Res. 103, 1383-1392.
6. Bogdanov, V. Y., Balasubramanian, V., Hathcock, J., Vele, O., Lieb, M., and Nemerson, Y. (2003). Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat. Med. 9, 458-462.
7. Borras, C., Gomez-Cabrera, M. C., and Vina, J. (2011). The dual role of p53: DNA protection and antioxidant. Free Radic. Res. 45, 643-652.
8. Brandes, R. P., Fleming, I., and Busse, R. (2005). Endothelial aging. Cardiovasc. Res. 66, 286-294.
9. Campisi, J., and d'Adda di Fagagna, F. (2007). Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740.
10. Carmeliet, P., and Jain, R. K. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473,298-307.
11. Carter, J. G., Cherry, J., Williams, K., Turner, S., Bates, D. O., and Churchill, A. J. (2011). Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease. Curr. Eye Res. 36, 328-335.
12. Cazalla, D., Zhu, J., Manche, L., Huber, E., Krainer, A. R., and Caceres, J. F. (2002). Nuclear export and retention signals in the RS domain of SR proteins. Mol. Cell. Biol. 22, 6871-6882.
13. Chang, M. W., Grillari, J., Mayrhofer, C., Fortschegger, K., Allmaier, G., Marzban, G., Katinger, H., and Voglauer, R. (2005). Comparison of early passage, senescent and hTERT immortalized endothelial cells. Exp. Cell Res. 309, 121-136.
14. Collins, C., and Tzima, E. (2011). Hemodynamic forces in endothelial dysfunction and vascular aging. Exp. Gerontol. 46, 185-188.
15. Conway, E. M., and Carmeliet, P. (2004). The diversity of endothelial cells: a challenge for therapeutic angiogenesis. Genome Biol. 5, 207.
16. Debacq-Chainiaux, F., Borlon, C., Pascal, T., Royer, V., Eliaers, F., Ninane, N., Carrard, G., Friguet, B., De Longueville, F., Boffe, S., Remacle, J., and Toussaint, O. (2005). Repeated exposure of human skin fibroblasts to UVB at subcyto-toxic level triggers premature senescence through the TGF-beta1 signaling pathway. J. Cell Sci. 118, 743-758.
17. Doetschman, T., Barnett, J. V., Runyan, R. B., Camenisch, T. D., Heimark, R. L., Granzier, H. L., Conway, S. J., and Azhar, M. (2012). Transforming growth factor beta signaling in adult cardiovascular diseases and repair. Cell Tissue Res. 347, 203-223.
18. Elias,A. P., and Dias, S. (2008). Microenvironment changes (in pH) affect VEGF alternative splicing. Cancer Microenviron. 1,131-139.
19. Erusalimsky, J. D. (2009). Vascular endothelial senescence: from mechanisms to pathophysiology. J. Appl. Physiol. 106, 326-332.
20. Erusalimsky, J. D., and Skene, C. (2009). Mechanisms of endothelial senescence. Exp. Physiol. 94,299-304.
21. Gerhard-Herman, M., Smoot, L. B., Wake, N., Kieran, M. W., Kleinman, M. E., Miller, D. T., Schwartzman, A., Giobbie-Hurder, A., Neuberg, D., and Gordon, L. B. (2012). Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome. Hypertension 59, 92-97.
22. Ghosh,A. K.,andVaughan,D. E. (2012). PAI-1 in tissue fibrosis. J. Cell. Physiol. 227, 493-507.
23. Giannakouros, T., Nikolakaki, E., Mylo-nis, I., and Georgatsou, E. (2011). Serine-arginine protein kinases: a small protein kinase family with a large cellular presence. FEBS J. 278, 570-586.
24. Grillari, J., Grillari-Voglauer, R., and Jansen-Durr, P. (2010). Post-translational modification of cellular proteins by ubiquitin and ubiquitin-like molecules: role in cellular senescence and aging. Adv. Exp. Med. Biol. 694,172-196.
25. Guil, S., Long, J. C., and Caceres, J. F. (2006). hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol. Cell. Biol. 26, 5744-5758.
26. Harries, L. W., Hernandez, D., Henley, W., Wood, A. R., Holly, A. C., Bradley-Smith, R. M., Yaghootkar, H., Dutta, A., Murray, A., Frayling, T. M., Guralnik, J. M., Bandinelli, S., Singleton, A., Ferrucci, L., and Melzer, D. (2011). Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing. Aging Cell 10, 868-878.
27. Indik, Z., Yeh, H., Ornstein-Goldstein, N., Kucich, U., Abrams, W., Rosen-bloom, J. C., and Rosenbloom, J. (1989). Structure of the elastin gene and alternative splicing of elastin mRNA: implications for human disease. Am. J. Med. Genet. 34, 81-90.
28. Konig, H., Matter, N., Bader, R., Thiele, W., and Muller, E (2007). Splicing segregation: the minor spliceosome acts outside the nucleus and controls cell proliferation. Cell 131, 718-729.
29. Krieglstein, K., Miyazono, K., Ten Dijke, P., and Unsicker, K. (2012). TGF-beta in aging and disease. Cell Tissue Res. 347, 5-9.
30. Li, H., and Liu, J. P. (2007). Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene. Ann. N. Y. Acad. Sci. 1114,56-68.
31. Lopez-Mejia, I. C., Vautrot, V., De Toledo, M., Behm-Ansmant, I., Bourgeois, C. F., Navarro, C. L., Oso-rio, E G., Freije, J. M., Stevenin, J., De Sandre-Giovannoli, A., Lopez-Otin, C., Levy, N., Branlant, C., and Tazi, J. (2011). A conserved splicing mechanism of the LMNA gene controls premature aging. Hum. Mol. Genet. 20,4540-4555.
32. Lopez-Novoa, J. M., and Bernabeu, C. (2010). The physiological role of endoglin in the cardiovascular system. Am. J. Physiol Heart Circ. Physiol. 299, H959-H974.
33. Manley, J. L., and Krainer, A. R. (2010). A rational nomenclature for serine/arginine-rich protein splicing factors (SRproteins). Genes Dev. 24, 1073-1074.
34. McClintock, D., Gordon, L. B., and Dja-bali, K. (2006). Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc. Natl.Acad. Sci. U.S.A. 103,2154-2159.
35. Meshorer, E., and Soreq, H. (2002). Pre-mRNA splicing modulations in senescence. Aging Cell 1, 10-16.
36. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22.
37. Nowak, D. G., Amin, E. M., Rennel, E. S., Hoareau-Aveilla, C., Gammons, M., Damodoran, G., Hagiwara, M., Harper, S. J., Woolard, J., Ladomery, M. R., and Bates, D. O. (2010). Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic iso-forms: a novel therapeutic strategy for angiogenesis. J. Biol. Chem. 285, 5532-5540.
38. Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., and Bates, D. O. (2008). Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J. Cell Sci. 121, 3487-3495.
39. Pascual, G., Mendieta, C., Garcia-Honduvilla, N., Corrales, C., Bellon, J. M., and Bujan, J. (2007). TGF-beta1 upregulation in the aging varicose vein. J. Vasc. Res. 44,192-201.
40. Patel,A.A.,andSteitz,J.A. (2003). Splicing double: insights from the second spliceosome. Nat. Rev. Mol. Cell Biol. 4, 960-970.
41. Perez-Gomez, E., Eleno, N., Lopez-Novoa, J. M., Ramirez, J. R., Velasco, B., Letarte, M., Bernabeu, C., and Quintanilla, M. (2005). Characterization of murine S-endoglin isoformandits effects on tumor development. Oncogene 24, 4450-4461.
42. Sanford, J. R., Ellis, J. D., Caza-lla, D., and Caceres, J. E (2005). Reversible phosphorylation differentially affects nuclear and cyto-plasmic functions of splicing factor 2/alternative splicing factor. Proc. Natl. Acad. Sci. U.S.A. 102, 15042-15047.
43. Santibanez, J. F., Quintanilla, M., and Bernabeu, C. (2011). TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin. Sci. 121, 233-251.
44. Schraml, E., Voglauer, R., Fortschegger, K., Sibilia, M., Stelzer, I., Grillari, J., and Schauenstein, K. (2008). Hap-loinsufficiency of senescence evasion factor causes defects of hematopoi-etic stem cells functions. Stem Cells Dev. 17, 355-366.
45. Semenza, G. L. (2007). Vasculogen-esis, angiogenesis, and arteriogen-esis: mechanisms of blood vessel formation and remodeling. J. Cell. Biochem. 102, 840-847.
46. Shay, J. W., and Wright, W. E. (2007). Hallmarks of telomeres in ageing research. J. Pathol. 211, 114-123.
47. Sheth, N., Roca, X., Hastings, M. L., Roeder, T., Krainer, A. R., and Sachidanandam, R. (2006). Comprehensive splicesite analysis using comparative genomics. Nucleic Acids Res. 34, 3955-3967.
48. Shomron, N., Alberstein, M., Reznik, M., and Ast, G. (2005). Stress alters the subcellular distribution of hSlu7 and thus modulates alternative splicing.J. CellSci. 118, 1151-1159.
49. Shovlin, C. L. (2010). Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 24,203-219.
50. Sinha, R., Allemand, E., Zhang, Z., Karni, R., Myers, M. P., and Krainer, A. R. (2010). Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF. Mol. Cell. Biol. 30, 2762-2774.
51. Szotowski, B., Antoniak, S., Poller, W., Schultheiss, H. P., and Rauch, U. (2005). Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ. Res. 96, 1233-1239.
52. Tang, J., Gordon, G. M., Nickoloff, B. J., and Foreman, K. E. (2002). The helix-loop-helix protein id-1 delays onset of replicative senescence in human endothelial cells. Lab. Invest. 82,1073-1079.
53. Trigueros-Motos, L., Gonzalez, J. M., Rivera, J., and Andres, V. (2011). Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress. Front. Biosci. (Schol. Ed.) 3, 1285-1297.
54. Velasco, S., Alvarez-Munoz, P., Per-icacho, M., Dijke, P. T., Bernabeu, C., Lopez-Novoa, J. M., and Rodriguez-Barbero, A. (2008). L-and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J. CellSci. 121,913-919.
55. Verduci, L., Simili, M., Rizzo, M., Mercatanti, A., Evangelista, M., Mariani, L., Rainaldi, G., and Pitto, L. (2010). MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J. Biol. Chem. 285,39551-39563.
56. Versari, D., Daghini, E., Virdis, A., Ghiadoni, L., and Taddei, S. (2009). Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br. J. Pharmacol. 157, 527-536.
57. Voglauer, R., Chang, M. W., Dampier, B., Wieser, M., Baumann, K., Sterovsky, T., Schreiber, M., Katinger, H., and Grillari, J. (2006). SNEV over expression extends the life span of human endothelial cells. Exp. Cell Res. 312, 746-759.
58. Will, C. L., Schneider, C., Hossbach, M., Urlaub, H., Rauhut, R., Elbashir, S., Tuschl, T., and Luhrmann, R. (2004). The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2dependent spliceosome. RNA 10, 929-941.
59. Worman, H. J., Fong, L. G., Muchir, A., and Young, S. G. (2009). Laminopathies and the long strange trip from basic cell biology to therapy.J. Clin. Invest. 119,1825-1836.
60. Xie, J., Lee, J. A., Kress, T. L., Mowry, K. L., and Black, D. L. (2003). Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc. Natl. Acad. Sci. U.S.A. 100, 8776-8781.